title: Ketamine, MK-801 or calmidazolium protects rat hippocampal energy status during in vitro ischemia.
authors.affiliation: Department of Anesthesiology, University of Nebraska Medical Center, Omaha 68198.
authors.forename: R
authors.initials: R
authors.lastname: Pohorecki
authors.forename: G L
authors.initials: GL
authors.lastname: Becker
authors.forename: P J
authors.initials: PJ
authors.lastname: Reilly
authors.forename: D F
authors.initials: DF
authors.lastname: Landers
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D002147:Calmodulin / Q000037:antagonists & inhibitors; D016291:Dizocilpine Maleate / Q000494:pharmacology*; D004734:Energy Metabolism / Q000187:drug effects*; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism*; D007093:Imidazoles / Q000494:pharmacology*; D066298:In Vitro Techniques; D002546:Ischemic Attack, Transient / Q000378:metabolism*; D007649:Ketamine / Q000494:pharmacology*; D007700:Kinetics; D051381:Rats
chemical_list: D002147:Calmodulin; D007093:Imidazoles; C031938:calmidazolium; D007649:Ketamine; D016291:Dizocilpine Maleate; D000255:Adenosine Triphosphate